Clinical Trials Browser

Not yet recruiting × Interventional × Genitourinary × Clear all

NCT07475533 2026-04-15

Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07518043 2026-04-15

A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

Phase 1 Not yet recruiting

DermatologicGenitourinary

Carcinoma, Transitional Cell, Melanoma

NCT07225309 2026-04-14

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Phase NA Not yet recruiting

BreastGastrointestinalGenitourinaryHead & Neck

Breast Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT07450599 2026-04-14

CHINANEO

Phase 2 Not yet recruiting

High-Risk Localized Prostate Cancer

NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

Phase NA Not yet recruiting

DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

NCT07529717 2026-04-14

CRIUS-1

Phase 1/2 Not yet recruiting

Prostatic Neoplasms

NCT06982222 2026-04-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Phase 1 Not yet recruiting

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT07297667 2026-04-13

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Phase 1 Not yet recruiting

BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT07407582 2026-04-13

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

Phase 1/2 Not yet recruiting

GenitourinaryHead & Neck

Head and Neck Neoplasms, Neoplasms, Testicular Neoplasms, Hearing Loss

NCT07516366 2026-04-13

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07524426 2026-04-13

LORUP

Phase NA Not yet recruiting

Urinary Bladder Neoplasms

NCT07526545 2026-04-13

UPRISE

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07526675 2026-04-13

Bioblation

Phase NA Not yet recruiting

Prostatic Hyperplasia, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT07526792 2026-04-13

SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Phase 3 Not yet recruiting

Carcinoma, Transitional Cell

NCT07518888 2026-04-09

ESCAPE

Phase NA Not yet recruiting

Motor Activity, Prostatic Neoplasms

NCT07518979 2026-04-09

MH-Penile-002

Phase 2 Not yet recruiting

Penile Neoplasms

NCT07354594 2026-04-08

ARREST

Phase 2 Not yet recruiting

Prostate Cancer Metastatic Castration-Resistant

NCT07516704 2026-04-08

Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study

Phase EARLY_PHASE1 Not yet recruiting

Prostatic Neoplasms

NCT07516808 2026-04-08

PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07463833 2026-04-07

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

Phase NA Not yet recruiting

Neoplasms, Prostatic Neoplasms

NCT07492381 2026-04-07

A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07515651 2026-04-07

MIDAS-SBRT

Phase 2 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07516210 2026-04-07

ART-Hypo

Phase 2 Not yet recruiting

GastrointestinalGenitourinaryGynecologic

Uterine Cervical Neoplasms, Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT07126548 2026-04-06

A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07290998 2026-04-06

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07510906 2026-04-06

P-PET

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07512076 2026-04-06

A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT07510334 2026-04-03

VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Phase 2 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT06549036 2026-04-02

Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07504835 2026-04-01

GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07463963 2026-03-30

RUPTURE

Phase NA Not yet recruiting

Urinary Bladder Neoplasms

NCT07500805 2026-03-30

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

Phase 1 Not yet recruiting

Carcinoma, Renal Cell

NCT07500831 2026-03-30

Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma

Phase NA Not yet recruiting

Carcinoma, Renal Cell

NCT07494435 2026-03-27

Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07495293 2026-03-27

Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT07497919 2026-03-27

A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer

Phase 2 Not yet recruiting

Penile Neoplasms

NCT07497958 2026-03-27

Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy

Phase NA Not yet recruiting

Carcinoma, Renal Cell, Acute Kidney Injury

NCT07493512 2026-03-25

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT07470840 2026-03-24

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07489495 2026-03-24

LITESPARK-034

Phase 3 Not yet recruiting

Carcinoma, Renal Cell

NCT07490210 2026-03-24

OMPC-RPM

Phase 2 Not yet recruiting

Oligometastatic Prostate Cancer

NCT06834204 2026-03-23

ACCESS-PC

Phase NA Not yet recruiting

GenitourinaryGynecologic

Adenocarcinoma, Urinary Bladder Neoplasms, Diabetes Mellitus, Hypercholesterolemia, Hyperlipidemias, Hypertension, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT07048314 2026-03-19

Stem Cells for Erectile Dysfunction Post RALP

Phase 1/2 Not yet recruiting

Erectile Dysfunction, Prostatic Neoplasms

NCT07468903 2026-03-19

Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07483658 2026-03-19

HYP-OP-RT

Phase NA Not yet recruiting

GastrointestinalGenitourinary

Gastrointestinal Diseases, Neoplasm Recurrence, Local, Prostatic Neoplasms, Radiation Injuries, Urologic Diseases

NCT07483970 2026-03-19

JL19001-NMIBC

Phase 1 Not yet recruiting

High Risk Non-muscle Invasive Bladder Cancer

NCT07145437 2026-03-18

PROSTERA

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07480044 2026-03-18

A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery

Phase NA Not yet recruiting

Emergence Delirium, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT07480356 2026-03-18

ADVANCED-3

Phase 3 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Neoplasms

NCT07322263 2026-03-17

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Phase 2 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell